A Miss Universe who thought it was just a mole, a college cheerleader who loved to tan: 4 women on having melanoma
Former Miss Universe Dayanara Torres knew she had a mole on the back of her leg for years, but didn't think much about it. 'I remember people talking to me about it,' she says. 'But because it was on the back of my leg, I would forget.'
The Married to Me author finally decided to take action in 2019, when she spotted the mole and realized that it was bigger than ever. Although she was traveling at the time, she was concerned enough to make an appointment to see a doctor in Miami before heading back to her home in Los Angeles. Torres says her doctor was pretty sure it was skin cancer, but when the biopsy confirmed that she had stage 3 melanoma, she was shocked.
'I have two kids, and I was a single mom. It was tough,' Torres tells Yahoo. She had surgery on her leg to remove the mole, along with surrounding areas of skin, which left her with 77 stitches. She started radiation treatment and immunotherapy every 21 days for a year after that.
Before her skin cancer diagnosis, Torrres says she didn't know anything about melanoma. After her experience, she decided to speak out about it, regularly sharing updates on her journey on social media. 'I wanted people to know and to understand,' she says. 'Each treatment, I would post a video just to keep people aware of what they should be looking for.' Torres participated in the Melanoma Research Foundation's 'Get Naked' campaign to encourage people to get their moles checked too. 'So many Latinos started doing appointments at their dermatologist because of me speaking out about it,' she says. 'It made me feel good.'
The 50-year-old is now diligent about putting on sunscreen before leaving the house, especially on her arms and face. She's also partnered with Coolibar, a brand that makes sun-protective shirts. 'Back in 2019, during my treatment, I was always wearing Coolibar,' she says. Torres says she makes a point to wear a hat and sunglasses while outdoors, and makes sure that 'every product I put on my face has SPF too.'
Torres urges other people to see a health care provider if they spot a suspicious spot. 'I could have detected it earlier — I just wasn't paying attention,' she says. 'You should pay attention to your skin. The earlier you detect it, the better the results.'
Melanoma can be fatal
Melanoma is the most deadly form of skin cancer, but it's highly treatable if it's caught early. According to the Melanoma Research Alliance (MRA), about 90% of melanomas are caused by exposure to UV (ultraviolet light). Getting five or more blistering sunburns between 15-20 years old can also raise your risk of getting melanoma by 80%, according to the MRA. There's also a genetic component. For some people, melanoma runs in their family, or they have certain traits, like fair skin and red hair, that raise the risk of getting this type of cancer. Also worth noting: Melanoma can crop up anywhere on the body, including the eyes, scalp, nails, mouth and feet, according to the Melanoma Research Foundation.
If you've had melanoma once, you're also at a higher risk of having it again, with research suggesting an up to 10% chance of a second melanoma, Dr. Hooman Khorasani, a dermatologic and cosmetic surgeon in private practice in New York City, tells Yahoo. 'This risk underscores the importance of regular full-body skin exams and lifelong skin surveillance,' he says.
It's also why Dr. Anthony Rossi, a dermatologist and Mohs surgeon at Memorial Sloan Kettering Cancer Center, always tells his patients to be 'sun smart' by wearing sunscreen with SPF 30 or higher daily, along with a hat and sunglasses. 'You don't have to be a vampire, but you shouldn't be tanning intentionally,' he tells Yahoo.
People who have had melanoma, like Torres, tell Yahoo that they're now conscientious about doing what they can to lower their risk of having cancer again — and they want to help others avoid going through the same thing.
'I had no education or experience with melanoma'
As a college cheerleader whose team was sponsored by a tanning salon, Kelly McWhinney tanned regularly in her late teens and early 20s. Like Torres, McWhinney didn't know what melanoma was or that tanning was a risk factor for developing the cancer. She was diagnosed with melanoma for the first time in 2022, followed by a metastatic form of melanoma in 2023.
'The first sign I noticed was a mole on my body that started getting bigger,' she tells Yahoo. 'When I had my recurrence, I noticed a sharp pain in my left breast that was caused by the enlarged lymph node in my armpit.'
McWhinney says she was shocked by her original diagnosis. 'I had no education or experience with melanoma and felt like I was left with no knowledge other than what the doctors told me, which at the time was very little,' she says. 'I reacted quickly by finding the best specialist in my area.'
She originally had the mole surgically removed, but a year later started having persistent chest pain. The melanoma had spread to her lymph nodes, creating a lymph node 17 times the normal size. McWhinney had it removed and started 26 rounds of immunotherapy treatment, but she had a severe reaction that changed her health.
'The treatment triggered extremely rare autoimmune complications, causing my immune system to attack my organs and resulting in medically induced hypothyroidism and type 1 diabetes,' she says. 'The cascade of treatment-related complications continued even after completing immunotherapy in July 2024, requiring removal of my gallbladder and tonsils, causing heavy menstrual bleeding and ovarian cysts and ultimately forcing me to have tubal ligation, ending my hopes for having more children.'
Now she uses sunscreen daily, rotating between Melan, Daily Shade, Sun Bum and Blue Lizard. McWhinney also wears sun-protective clothes by Watskin and Lands' End. 'I always aim for shade when outside,' she says.
McWhinney has partnered with the Melanoma Research Alliance to spread awareness of the disease and urges other people to think of getting skin checks as a vital part of their health care. 'It is a necessity. It is equally as important as a Pap or a mammogram,' she says. 'I would also love for others to understand that melanoma will never 'just' be skin cancer. It is a cancer that is quick, sneaky and shows up everywhere, including large organs. Melanoma can change your life in every single way.'
'I started having difficulty breathing'
It was Mother's Day when Juanita Taylor felt like something was wrong. 'I was sitting on the sofa and I started having difficulty breathing,' she tells Yahoo. Taylor has a history of heart issues, so she called 911.
'I went to the ER, and they couldn't find anything happening with my heart,' she says. But doctors also did a chest X-ray and discovered that there was a small shadow on the back of her chest. 'Eventually, they saw there was a mass,' she says. A biopsy revealed that she had melanoma. 'I had no outward signs. It's not normal, especially for a person of color,' Taylor says. 'The only thing I'd had previously was a cough.' (While it's not common, melanomas do start in the lungs on rare occasions.)
Taylor, who was 61 at the time, had surgery at MD Anderson Cancer Center to remove the mass, along with a portion of her lung. 'That was the only treatment I had,' she says.
Even though her melanoma was internal, Taylor says she's had friends who have had melanomas on their skin. She's now diligent about sun protection as a result. 'I try not to go out at midday,' she says. 'I have a big sun hat that I wear, even in the wintertime. It covers the upper part of my body.' Taylor also makes a point to use a body lotion with SPF that's certified by the Skin Cancer Foundation.
'Know your own body,' Taylor says. 'When I had shortness of breath, I knew the body was telling me that something was amiss.'
'I've had melanoma four times'
Nancy Stokes was first diagnosed with melanoma in 2008. She's had three more since then. Stokes tells Yahoo that she was warned she might develop melanoma after a dermatologist spotted and removed a precancerous lesion from her chest when she was in her 20s.
'I started having annual skin checks after that,' she says. While Stokes says her dermatologist has caught most of her melanomas, she spotted one on her ankle that her doctor initially cleared. 'I actually caught that one,' she says.
Stokes says she's grateful that her regular skin checks have identified these cancers early. 'The worst one I had was very early stage, but on my temple. They were worried it was going to damage my temporal nerve and the whole side of my face,' she says, noting that she went to see specialists at Memorial Sloan Kettering Cancer Center for surgery. 'Luckily, somehow it didn't,' she added.
Stokes says she's now strict about protecting her skin from the sun. 'For my daily routine, I use Elizabeth Arden Prevage face cream — that has sunscreen in it,' she says. Stokes also uses a tinted moisturizer with SPF.
'For my body, I just cover up,' she says. 'If I'm going to be in the sun, I wear a hat with an SPF liner.' Stokes also wears bathing suits with UPF sleeves (brands like Outdoor Research and Coolibar also make UPF sleeves you can wear with any outfit). And when she's at the beach, Stokes says her husband will set up an umbrella before she gets there to make sure she's in the shade as much as possible.
Stokes is also diligent about seeing a dermatologist. 'Getting your skin checked is the name of the game,' she says.
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target
Johnson & Johnson (NYSE:JNJ) ranks among the . On July 16, Stifel maintained its Hold rating on Johnson & Johnson (NYSE:JNJ), but increased its price target for the healthcare giant from $155 to $165. The price target increase comes after JNJ revised its outlook, which now predicts adjusted operational revenue growth of roughly 3.5% instead of the 2.5% midpoint estimate that was previously projected. Pixabay/Public Domain Johnson & Johnson (NYSE:JNJ) also raised its outlook for full-year earnings per share from $10.50 to $10.70 to a range of $10.80 to $10.90. The company cited stronger top-line performance, currency effects, and a lower anticipated impact from tariffs for this improvement. From its initial estimate of $400 million, the healthcare company now projects a $200 million tariff impact in 2025. Johnson & Johnson (NYSE:JNJ) is a notable name in the healthcare industry, which includes sub-sectors like pharmaceuticals, medical equipment, and consumer health products. The company is known for creating medications to treat a variety of conditions and diseases, including cancer, diabetes, and HIV/AIDS. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Read More: and Disclosure: None. Sign in to access your portfolio


Medscape
29 minutes ago
- Medscape
Claims Data Fail to Accurately Identify MI Types
TOPLINE: Clinical auditing reveals significant misclassification in administrative codes for myocardial infarction (MI), with only 39% of type 1 (T1MI) codes and 72% of type 2 (T2MI) codes for the condition accurately reflecting the true diagnosis, researchers found. Nearly half of patients coded for T1MI had T2MI, whereas 26% of T2MI codes represented myocardial injury. METHODOLOGY: Researchers identified 350 randomly sampled patients with T1MI codes and 350 patients with T2MI codes during inpatient encounters using the International Statistical Classification of Diseases and Related Health Problems-10th Revision. The analysis included patients aged 65 years and older from October 1, 2017, to May 9, 2024, within eight hospitals in the Mass General Brigham system. Using the 4th Universal Definition of MI, the researchers reviewed the clinical encounters to assess evidence of plaque erosion or thrombus vs oxygen demand-supply imbalance. A second physician review was conducted for 146 challenging and 146 nonchallenging cases. TAKEAWAY: Among the 350 patients coded as having had T1MI, clinical adjudication revealed 138 (39%) as correctly diagnosed; 159 (45%) in fact had T2MI, and 35 (10%) had myocardial injury. Of the 350 patients coded as having had T2MI, 251 (72%) were confirmed, four (1%) were found to have T1MI, and 91 (26%) had myocardial injury. A second physician review demonstrated a high degree of agreement with the initial review, with a 94% agreement in nonchallenging cases and 86% in challenging cases. Hospitals equipped with vs without cardiac catheterization laboratories showed significantly lower misclassification rates (43% vs 58%; P = .0298). IN PRACTICE: 'Among individuals assigned a T1MI claims code, nearly one half have T2MI and many others have myocardial injury; fewer than one half have true T1MI,' the researchers reported. 'Our results also confirm and extend previous work showing that among those with T2MI codes, slightly more than one half have true T2MI, with most of the misclassification related to myocardial injury rather than T1MI. This has critically important implications for epidemiology and public policy' related to acute myocardial infarction. SOURCE: The study was led by Andrea Martinez, MD, of the Department of Medicine at Massachusetts General Hospital, Boston. It was published online on July 21 in Journal of the American College of Cardiology. LIMITATIONS: The results may not be generalized to other hospital systems and countries, where patterns of misclassification might differ. The researchers noted external validity assessment across multiple healthcare systems and in countries that have already introduced International Classification of Diseases-11th revision coding would be beneficial. While patterns of misclassification might have changed over time, the analysis was intentionally restricted to the period when codes for both T1MI and T2MI were available. DISCLOSURES: The study received support through a grant to Jason Wasfy from the Massachusetts General Hospital Executive Committee on Research. Individual authors reported receiving other grants and support, including grants from industry. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Yahoo
32 minutes ago
- Yahoo
COVID-19 cases are on the rise in MA, CDC says. What to know about 'Nimbus' strain.
COVID-19 numbers are rising in Massachusetts, and in states across the country. "COVID-19 laboratory percent positivity is increasing nationally," according to the Centers for Disease Control and Prevention (CDC) website. "Emergency department visits for COVID-19 are increasing among young children 0-4 years old," though the CDC noted that emergency room visits are "low" overall. The latest COVID-19 strain is known as "Nimbus." Here's what to know. Are COVID-19 numbers increasing in Massachusetts? The CDC website has evaluated the issue in each state and determined cases in Massachusetts are likely rising. In Massachusetts, there is an 85.8% chance that COVID-19 numbers are increasing, according to the CDC. The Massachusetts Department of Public Health (DPH) reported that as of June 28, there were 377 confirmed cases of COVID and 77 unconfirmed cases. No COVID-19 deaths were reported at the time. The data stops in June because the Massachusetts DPH "ended data collection for the 2024-2025 viral respiratory season on June 28, 2025, and routine updates to their dashboard for the 2025-2026 season will resume later this summer." What is the current COVID-19 strain 'Nimbus?' As of early June, the new strain known as NB.1.8.1, or "Nimbus," made up 37% of COVID-19 cases nationwide. Variant NB.1.8.1 was first detected in China in January 2025 but accounted for about 0% of cases in the United States until May. The World Health Organization added at the time that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease." Virologists describe Nimbus as a 'slightly upgraded' version of its predecessor. While there is no evidence it causes more severe disease, it appears to be highly transmissible. What are the symptoms of Nimbus? Reported symptoms of NB.1.8.1 are similar to other COVID-19 strains, but one distinctive complaint is a severe sore throat, sometimes described as 'razor-blade throat fatigue.' Other symptoms may include: Mild cough Fever Muscle aches Nasal congestion Are vaccines still effective? Health experts say that updated COVID-19 vaccines remain the best protection against severe illness. Vaccination rates vary widely by state, and health officials continue to urge eligible individuals to stay current with their shots. How can people get tested? People can either take an at-home test or they can see their respective doctors. (This story was updated because an earlier version included an inaccuracy.) This article originally appeared on COVID cases on rise in MA, CDC says. What to know about latest strain Solve the daily Crossword